Metropolitan Life Insurance CO Allogene Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

42 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$2.92 - $5.63 $5,667 - $10,927	1,941 Added 112.65%	3,664 $16,000
Q4 2023 Feb 14, 2024	SELL	$2.28 - $3.5 $5,969 - $9,163	-2,618 Reduced 60.31%	1,723 $5,000
Q1 2023 May 15, 2023	SELL	$4.92 - $8.21 $6,779 - $11,313	-1,378 Reduced 24.1%	4,341 $21,000
Q4 2022 Jun 14, 2023	BUY	$5.62 - $11.11 $7,744 - $15,309	1,378 Added 31.74%	5,719 $36 Million
Q4 2022 Mar 30, 2023	BUY	$5.62 - $11.11 $7,227 - $14,287	1,286 Added 29.01%	5,719 $35,000
Q4 2022 Feb 15, 2023	BUY	$5.62 - $11.11 $7,227 - $14,287	1,286 Added 29.01%	5,719 $35,000
Q3 2022 Jun 14, 2023	BUY	$10.32 - $17.28 $949 - $1,589	92 Added 2.12%	4,433 $47.9 Million
Q2 2022 Jun 20, 2023	BUY	$6.78 - $12.28 $623 - $1,129	92 Added 2.12%	4,433 $50,000
Q1 2022 Jun 20, 2023	BUY	$7.65 - $15.29 $703 - $1,406	92 Added 2.12%	4,433 $40,000
Q1 2022 Mar 30, 2023	SELL	$7.65 - $15.29 $103,129 - $206,124	-13,481 Reduced 75.25%	4,433 $40,000
Q1 2022 May 12, 2022	SELL	$7.65 - $15.29 $103,129 - $206,124	-13,481 Reduced 75.25%	4,433 $40,000
Q4 2021 Jun 21, 2023	BUY	$13.13 - $24.52 $178,213 - $332,809	13,573 Added 312.67%	17,914 $267,000
Q4 2021 Mar 30, 2023	SELL	$13.13 - $24.52 $14,915 - $27,854	-1,136 Reduced 5.96%	17,914 $267,000
Q4 2021 Feb 15, 2022	SELL	$13.13 - $24.52 $14,915 - $27,854	-1,136 Reduced 5.96%	17,914 $267,000
Q3 2021 Jun 21, 2023	BUY	$21.01 - $27.64 $309,036 - $406,556	14,709 Added 338.84%	19,050 $489,000
Q2 2021 Jun 21, 2023	BUY	$23.49 - $35.8 $345,514 - $526,582	14,709 Added 338.84%	19,050 $496,000
Q2 2021 Mar 30, 2023	BUY	$23.49 - $35.8 $86,584 - $131,958	3,686 Added 23.99%	19,050 $496,000
Q2 2021 Aug 16, 2021	BUY	$23.49 - $35.8 $447,132 - $681,453	19,035 Added 126900.0%	19,050 $497,000
Q1 2021 Jun 26, 2023	BUY	$25.79 - $39.02 $284,283 - $430,117	11,023 Added 253.93%	15,364 $542 Million
Q1 2021 Mar 30, 2023	SELL	$25.79 - $39.02 $11,992 - $18,144	-465 Reduced 2.94%	15,364 $542,000
Q1 2021 May 14, 2021	SELL	$25.79 - $39.02 $407,843 - $617,062	-15,814 Reduced 99.91%	15 $542,000
Q4 2020 Jun 22, 2023	BUY	$25.24 - $43.45 $289,957 - $499,153	11,488 Added 264.64%	15,829 $399,000
Q4 2020 Mar 30, 2023	BUY	$25.24 - $43.45 $5,880 - $10,123	233 Added 1.49%	15,829 $399,000
Q4 2020 Feb 16, 2021	BUY	$25.24 - $43.45 $5,880 - $10,123	233 Added 1.49%	15,829 $400,000
Q3 2020 Jun 26, 2023	BUY	$32.38 - $44.96 $364,436 - $506,024	11,255 Added 259.27%	15,596 $588,000
Q3 2020 Mar 30, 2023	BUY	$32.38 - $44.96 $23,022 - $31,966	711 Added 4.78%	15,596 $588,000
Q3 2020 Nov 13, 2020	BUY	$32.38 - $44.96 $23,022 - $31,966	711 Added 4.78%	15,596 $588,000
Q2 2020 Jun 26, 2023	BUY	$18.39 - $54.04 $193,904 - $569,797	10,544 Added 242.89%	14,885 $637,000
Q2 2020 Mar 30, 2023	BUY	$18.39 - $54.04 $34,131 - $100,298	1,856 Added 14.25%	14,885 $637,000
Q2 2020 Aug 14, 2020	BUY	$18.39 - $54.04 $34,131 - $100,298	1,856 Added 14.25%	14,885 $637,000
Q1 2020 Jul 12, 2023	BUY	$18.22 - $28.25 $158,295 - $245,436	8,688 Added 200.14%	13,029 $253,000
Q4 2019 Jul 12, 2023	BUY	$24.82 - $31.4 $215,636 - $272,803	8,688 Added 200.14%	13,029 $338,000
Q3 2019 Jul 12, 2023	BUY	$26.11 - $32.99 $226,843 - $286,617	8,688 Added 200.14%	13,029 $355,000
Q3 2019 Mar 30, 2023	BUY	$26.11 - $32.99 $111,411 - $140,768	4,267 Added 48.7%	13,029 $355,000
Q3 2019 Nov 14, 2019	BUY	$26.11 - $32.99 $111,411 - $140,768	4,267 Added 48.7%	13,029 $355,000
Q2 2019 Jul 12, 2023	BUY	$25.56 - $31.09 $144,362 - $175,596	5,648 Added 130.11%	9,989 $268,000
Q1 2019 Jul 13, 2023	BUY	$24.82 - $32.54 $109,729 - $143,859	4,421 Added 101.84%	8,762 $253,000
Q1 2019 Mar 30, 2023	BUY	$24.82 - $32.54 $75,527 - $99,019	3,043 Added 53.21%	8,762 $253,000
Q1 2019 May 16, 2019	SELL	$24.82 - $32.54 $940,802 - $1.23 Million	-37,905 Reduced 81.22%	8,762 $253,000
Q1 2019 May 15, 2019	BUY	$24.82 - $32.54 $928,565 - $1.22 Million	37,412 Added 404.24%	46,667 $1.24 Million
Q4 2018 Jul 13, 2023	BUY	$22.5 - $33.3 $110,565 - $163,636	4,914 Added 113.2%	9,255 $249,000
Q4 2018 Feb 14, 2019	BUY	$22.5 - $33.3 $208,237 - $308,191	9,255 New	9,255 $249,000

Others Institutions Holding ALLO

# of Institutions

163

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $233M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account